TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Xellia Pharmaceuticals AS
Closing information (x1000 SEK)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 81,088 | 80,543 | 83,594 |
Financial expenses | 20 | 35 | 8,728 |
Earnings before taxes | 26,785 | 28,811 | 7,446 |
Total assets | 635,071 | 589,504 | 550,910 |
Current assets | 158,471 | 126,588 | 104,120 |
Current liabilities | 22,418 | 21,210 | 22,197 |
Equity capital | 606,170 | 560,931 | 520,650 |
- share capital | 236,180 | 228,722 | 223,470 |
Employees (average) | 43 | ||
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 95.4% | 95.2% | 94.5% |
Turnover per employee | 1,944 | ||
Profit as a percentage of turnover | 33.0% | 35.8% | 8.9% |
Return on assets (ROA) | 4.2% | 4.9% | 2.9% |
Current ratio | 706.9% | 596.8% | 469.1% |
Return on equity (ROE) | 4.4% | 5.1% | 1.4% |
Change turnover | -2,082 | -5,015 | -862 |
Change turnover % | -3% | -6% | -1% |
Chg. No. of employees | -4 | ||
Chg. No. of employees % | -9% |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.